Phyllis B. Malpas

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis et al. · Clinical Cancer Research · 2009 · 416 citations · Full text

Risk Assessment of Microcystin in Dietary Aphanizomenon flos-aquae

David J. Schaeffer, Phyllis B. Malpas, Larry L. Barton · Ecotoxicology and Environmental Safety · 1999 · 51 citations

Risk Assessment, Management, Food Contaminant +5

The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog

Wendy T. Collard, Bernard D. Hummel, A. F. Fielder et al. · Journal of Veterinary Pharmacology and Therapeutics · 2013 · 50 citations

In Vitro Drug-Drug Interaction Screens for Canine Veterinary Medicines: Evaluation of Cytochrome P450 Reversible Inhibition

Divesh Aidasani, Matthew J. Zaya, Phyllis B. Malpas et al. · Drug Metabolism and Disposition · 2008 · 35 citations